Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Underperformed due to guidance being revised to the low end of the range because of sales and margin headwinds in the infant formula segment. Held because of...
— ArrowMark Partners
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Perrigo Company plc
Perrigo (PRGO) +42.1%. Our biggest loser...
Perrigo was our biggest loser in 2025 at -46%, and the pain continued into Q1.
More institutional theses from Meridian Contrarian Fund
Axis Capital is a specialty insurer experiencing a successful operational turnaround under a new management team. The company has...
Cameco is a leading low-cost uranium producer that has benefited from a structural supply deficit and growing interest in nuclear power. Although the stock...
The Honest Company specializes in natural household and baby products, which the fund bought as a contrarian play after supply chain disruptions. Despite strong earnings,...